Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eli Lilly and Company : - Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference

11/25/2020 | 09:56am EST

INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020.

Michael Mason, Lilly senior vice president and president of Lilly Diabetes and Connected Care, will participate in a virtual fireside chat at 2:40 p.m., Eastern Time.

A live audio webcast will be available on the 'Webcasts & Presentations' section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Contact:

Kevin Hern

Tel: (317) 277-1838

Email: hernkevinr@lilly.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about ELI LILLY AND COMPANY
10:56aELI LILLY AND : BofA Securities Adjusts Eli Lilly and Company PT to $225 From $1..
MT
04:59aELI LILLY AND COMPANY : - Lilly's neutralizing antibody bamlanivimab prevented C..
AQ
01/21ELI LILLY AND : Says Trial of Monoclonal Antibody Among Nursing Home, Staff Resi..
MT
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
AQ
01/21ELI LILLY AND : Says Late-Stage Trial Shows Antibody Bamlanivimab Effective in P..
MT
01/21Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds
DJ
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
PR
01/20ELI LILLY AND : (LLY) Insider Makes Significant Share Sale
MT
01/20ELI LILLY AND : Thinking about trading options or stock in General Motors, Eli L..
PR
01/20FULCRUM THERAPEUTICS : Announces Promotion of Christopher Moxham Ph.D. to Chief ..
AQ
More news
Financials (USD)
Sales 2020 24 415 M - -
Net income 2020 5 821 M - -
Net Debt 2020 11 301 M - -
P/E ratio 2020 32,3x
Yield 2020 1,44%
Capitalization 187 B 187 B -
EV / Sales 2020 8,12x
EV / Sales 2021 7,12x
Nbr of Employees 33 625
Free-Float 99,8%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | LLY | US5324571083 | MarketScreener
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 191,87 $
Last Close Price 206,14 $
Spread / Highest target 10,1%
Spread / Average Target -6,92%
Spread / Lowest Target -41,8%
EPS Revisions
Managers and Directors
NameTitle
David A. Ricks Chairman, President & Chief Executive Officer
Joshua L. Smiley Chief Financial Officer & Senior Vice President
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Aarti S. Shah Chief Information & Digital Officer, Senior VP
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY19.85%183 447
JOHNSON & JOHNSON2.76%425 761
ROCHE HOLDING AG2.51%306 541
NOVARTIS AG2.34%219 658
MERCK & CO., INC.-0.76%205 388
PFIZER INC.-0.90%202 770